Todas as matérias desta seção, das mais recentes às mais antigas — página 141 de 371.
Agilent Technologies (NYSE:A) completed its previously announced $950 million acquisition of Biocare Medical, adding the clinical pathology company to its Life Sciences and Diagnostics Markets Group.
Virtuix (NASDAQ:VTIX) reported fiscal 2026 net sales of $4.3 million, an increase of 18% from the prior year.
Willis Lease Finance (NASDAQ:WLFC) closed the acquisition of three Airbus A330-300 aircraft on June 25, 2026.
Kustom Entertainment (NASDAQ:KUST) agreed to divest its legacy video solutions division to Cycurion (NASDAQ:CYCU), with consideration totaling up to $5.5 million plus 2,000,000 Cycurion warrants.
Triple Flag Precious Metals (NYSE:TFPM) announced that its wholly owned subsidiary has completed the acquisition of a gold stream on the producing Ravenswood Gold Mine in Queensland, Australia.
Z Squared (NASDAQ:ZSQR) signed a binding letter of intent to acquire a majority interest in Paradox Data for $5 million in newly designated Series D Convertible Preferred Stock.
BlackBerry (NYSE:BB) reported Q1 FY2027 revenue of $152.9 million, up 26% year over year, with adjusted gross margin of 78.6%.
TD SYNNEX (NYSE:SNX) announced record fiscal second quarter revenue of $19.6 billion, an increase of 31% year over year and 29.1% in constant currency.
Winnebago Industries (NYSE:WGO) reported fiscal 2026 third-quarter net revenues of $698.7 million, down 9.9% year over year, with gross margin steady at 13.6%.
Yiren Digital (NYSE:YRD) reported Q1 2026 total net revenue of RMB915.1 million, down 41% year over year, as the company moved to a net loss.
Darden Restaurants (NYSE:DRI) reported fourth quarter fiscal 2026 sales of $3.72 billion, an increase of 13.7% from the prior-year period.
CMC (NYSE:CMC) reported fiscal 2026 third-quarter net earnings of $173 million, or $1.55 per diluted share, on net sales of $2.48 billion.
Merck (NYSE:MRK) announced that the U.S. Food and Drug Administration approved KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph), each in combination with Trodelvy (sacituzumab govitecan-hziy), for the first-line treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer whose tumors express PD-L1 (CPS ≥10).
Apogee Enterprises (NASDAQ:APOG) said its board declared a quarterly cash dividend of $0.27 per share, keeping shareholder returns in focus.
McCormick (NYSE:MKC) reported second quarter 2026 net sales growth of 16.7%, driven by 1.7% organic growth and a 2.7% positive currency impact.
ProQR Therapeutics (NASDAQ:PRQR) reported positive Phase 1 target engagement data for AX-0810, its first Axiomer RNA editing candidate, in healthy volunteers.
Merck KGaA, Darmstadt, Germany has agreed to acquire Bio-Techne (NASDAQ:TECH) for $73 per share in cash, implying an enterprise value of $11.3 billion.
Acuity (NYSE:AYI) reported fiscal 2026 third-quarter net sales of $1.2 billion, up about 2% from a year earlier, as operating profit rose 38% to $193.3 million.
DeepHealth, a subsidiary of RadNet (NASDAQ:RDNT), received two FDA 510(k) clearances for its AI-powered Breast Suite, branded as Mammo Dx
Petrobras (NYSE:PBR) said its flagship Búzios field reached a record average production of 1.1 million barrels of oil per day, surpassing the previous record of 1 million barrels per day achieved in October 2025.
Amazon (NASDAQ:AMZN) said it will invest an additional $13 billion in India by 2030 to expand and support AI and cloud infrastructure.
Wendy’s exploded up to 42% intraday on June 24, halting for volatility after a viral WallStreetBets post called on traders to “save Wendy’s before it’s too late.”
H.B. Fuller (NYSE:FUL) made a recommended cash offer to acquire Advanced Medical Solutions for £715 million, expanding its medical adhesives portfolio.
-640x360.webp&w=3840&q=75)